Prosecution Insights
Last updated: November 11, 2026

Takahiro Ochiya

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Takahiro Ochiya currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single matter is being handled by 1 distinct examiner, TURPIN, ZACHARY MARK. The prosecution is localized within 1 distinct art unit, reflecting a focused technical scope for the current active application. Because there is only 1 pending office action, TURPIN, ZACHARY MARK also serves as the busiest examiner with 1 pending matter.

The concentration of the portfolio into 1 distinct art unit and 1 distinct examiner means that the immediate success of the company's patent strategy in Biotechnology & Pharmaceuticals relies on a single point of contact. The presence of 1 pending office action indicates a limited volume of current activity at the patent office. This singular focus allows for a direct prosecution approach with TURPIN, ZACHARY MARK, as there are no other examiners or art units to coordinate with at this time.

With 1 pending office action and 1 distinct examiner, the data shows no fragmentation in the company's current legal efforts. The specific requirements of the 1 distinct art unit will dictate the technical hurdles for the pending matter. As the busiest examiner, TURPIN, ZACHARY MARK holds the entirety of the company's 1 pending office action, making his individual examination style the primary factor in this portfolio's current status.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
TURPIN, ZACHARY MARK 1 3.8% -4.8%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17618412 METHOD FOR PREDICTING DEVELOPMENT OF SEVERE SYMPTOM OF COVID-19 USING EXOSOMAL PROTEIN MARKER IN BLOOD TURPIN, ZACHARY MARK —

Top Art Units

Art UnitApps
1682 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17618412 METHOD FOR PREDICTING DEVELOPMENT OF SEVERE SYMPTOM OF COVID-19 USING EXOSOMAL PROTEIN MARKER IN BLOOD TURPIN, ZACHARY MARK 1682 §101§102§103§112 Non-Final OA — Pending Oct 24, 2023

Managing Takahiro Ochiya's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Takahiro Ochiya have?

Takahiro Ochiya has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Takahiro Ochiya applications?

Zachary Mark Turpin has the most, with 1 of Takahiro Ochiya's pending office actions.

What technology area are Takahiro Ochiya's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month